Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and C. elegans-Based Innovations

被引:6
|
作者
Yoon, Sunhee [1 ]
You, Dilara Kilicarslan [1 ]
Jeong, Uiechan [2 ]
Lee, Mina [1 ]
Kim, Eunhye [1 ]
Jeon, Tae-Joon [1 ,3 ,4 ]
Kim, Sun Min [1 ,2 ,4 ]
机构
[1] Inha Univ, Dept Biol Sci & Bioengn, Incheon 22212, South Korea
[2] Inha Univ, Dept Mech Engn, Incheon 22212, South Korea
[3] Inha Univ, Dept Biol Engn, Incheon 22212, South Korea
[4] Inha Univ, Biohybrid Syst Res Ctr BSRC, Incheon 22212, South Korea
来源
BIOSENSORS-BASEL | 2024年 / 14卷 / 01期
基金
新加坡国家研究基金会;
关键词
biochips; C; elegans; drug screening; microfluidics; cell chip; organ-on-a-chip; CAENORHABDITIS-ELEGANS; MODEL; CELL; DEVICES; PDMS; ABSORPTION; DISCOVERY; PLATFORM; NEURONS; DESIGN;
D O I
10.3390/bios14010055
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The development of therapeutic interventions for diseases necessitates a crucial step known as drug screening, wherein potential substances with medicinal properties are rigorously evaluated. This process has undergone a transformative evolution, driven by the imperative need for more efficient, rapid, and high-throughput screening platforms. Among these, microfluidic systems have emerged as the epitome of efficiency, enabling the screening of drug candidates with unprecedented speed and minimal sample consumption. This review paper explores the cutting-edge landscape of microfluidic-based drug screening platforms, with a specific emphasis on two pioneering approaches: organ-on-a-chip and C. elegans-based chips. Organ-on-a-chip technology harnesses human-derived cells to recreate the physiological functions of human organs, offering an invaluable tool for assessing drug efficacy and toxicity. In parallel, C. elegans-based chips, boasting up to 60% genetic homology with humans and a remarkable affinity for microfluidic systems, have proven to be robust models for drug screening. Our comprehensive review endeavors to provide readers with a profound understanding of the fundamental principles, advantages, and challenges associated with these innovative drug screening platforms. We delve into the latest breakthroughs and practical applications in this burgeoning field, illuminating the pivotal role these platforms play in expediting drug discovery and development. Furthermore, we engage in a forward-looking discussion to delineate the future directions and untapped potential inherent in these transformative technologies. Through this review, we aim to contribute to the collective knowledge base in the realm of drug screening, providing valuable insights to researchers, clinicians, and stakeholders alike. We invite readers to embark on a journey into the realm of microfluidic-based drug screening platforms, fostering a deeper appreciation for their significance and promising avenues yet to be explored.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Engineering a Brain Cancer Chip for High-throughput Drug Screening
    Yantao Fan
    Duong Thanh Nguyen
    Yasemin Akay
    Feng Xu
    Metin Akay
    Scientific Reports, 6
  • [32] High-throughput tracking enables systematic phenotyping and drug repurposing in C. elegans disease models
    O'Brien, Thomas J.
    Barlow, Ida L.
    Feriani, Luigi
    Brown, Andre E. X.
    ELIFE, 2025, 12
  • [33] High-throughput behavioral screen in C. elegans reveals Parkinson's disease drug candidates
    Sohrabi, Salman
    Mor, Danielle E.
    Kaletsky, Rachel
    Keyes, William
    Murphy, Coleen T.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [34] High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates
    Salman Sohrabi
    Danielle E. Mor
    Rachel Kaletsky
    William Keyes
    Coleen T. Murphy
    Communications Biology, 4
  • [35] High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics
    Ben-Yakar, Adela
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2019, 17 (01) : 8 - 13
  • [36] Unlocking The Potential Of Organ-on-chip For Drug Development And Discovery Through Precision Microfluidics, Integrated Sensing, And High-throughput Platforms
    Petrie, T. A.
    TISSUE ENGINEERING PART A, 2023, 29 (9-10)
  • [37] Development of high-throughput liver-on-a-chip for drug toxicity screening
    Wilschut, K.
    Annida, R. J.
    Wang, Z.
    Ng, C.
    Shevchenko, V.
    Chesne, C.
    Joore, J.
    TOXICOLOGY LETTERS, 2018, 295 : S111 - S112
  • [38] High-throughput Screening and Biosensing with Fluorescent C-elegans Strains
    Leung, Chi K.
    Deonarine, Andrew
    Strange, Kevin
    Choe, Keith P.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2011, (51):
  • [39] Revolutionizing Drug Discovery: The Impact of Distinct Designs and Biosensor Integration in Microfluidics-Based Organ-on-a-Chip Technology
    Yuan, Sheng
    Yuan, Huipu
    Hay, David C.
    Hu, Huan
    Wang, Chaochen
    BIOSENSORS-BASEL, 2024, 14 (09):
  • [40] High-throughput in vivo genetic and drug screening using femtosecond laser microsurgery and microfluidics
    Rohde, C. B.
    Zeng, F.
    Gilleland, C.
    Gonzalez-Rubio, R.
    Angel, M.
    Yanik, M. F.
    2008 CONFERENCE ON LASERS AND ELECTRO-OPTICS & QUANTUM ELECTRONICS AND LASER SCIENCE CONFERENCE, VOLS 1-9, 2008, : 57 - 57